The YouTube Music app is primarily designed for mobile devices, but if you’re looking for a similar experience on your PC, you can still access it in various ways. There is currently no dedicated ...

Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...

The battle to sell weight-loss pills is heating up, and Hims & Hers Health just undercut its rival on price.

Within hours of Hims and Hers Health's announcement, Novo Nordisk also issued a statement, saying that it would take legal action against the company in the interest of patients(AP) Shares of Novo ...

Taylor Swift selected one of Travis Kelce's favorite songs from “The Life of a Showgirl” to be her next music video from the album. On Feb. 6, the singer debuted a music video for "Opalite," a song ...

Hims & Hers Health (HIMS) fell ~8% in the premarket on Friday after FDA Commissioner Marty Makary said that his agency will take swift action against “companies mass-marketing illegal copycat drugs.” ...

With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the United States’ top drug regulator has taken notice. “FDA will take swift action ...

FDA leadership indicated planned swift enforcement against companies mass-marketing non-approved “copycat” drugs, underscoring inability to verify safety, quality, or effectiveness outside the ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. The US drug regulator plans to crack down on copycat versions of popular weight-loss drugs sold by Hims & ...

Taylor Swift isn’t through with her showgirl era just yet. The pop star just released the music video for her next The Life of a Showgirl single, “Opalite” — and it’s full of lightning-strike twists.

US Food and Drug Administration (FDA) Commissioner Marty Makary said the agency would target the mass-marketing of unapproved drugs amid ongoing opposition between drugmakers and online telehealth ...

Novo Nordisk has also spoken out strongly against Hims & Hers’ compounded Wegovy pill, with CEO Maziar Mike Doustdar telling investors the knockoff version is a waste of money. The FDA will “take ...